Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Augustin

Showing results (421-430 of 491) with videos related to

Pageof 50
Sort By:
American Journal of Clinical Dermatology|November 15, 2024
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III StudiesEric L Simpson, Matthias Augustin, Diamant Thaçi, et al.
Psoriasis (Auckland, N.Z.)|May 20, 2024
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest RegistriesMaría José Valencia López, Brigitte Stephan, Anna Meineke, et al.
Biomedicines|October 26, 2024
Assessment and Monitoring of the Wound Micro-Environment in Chronic Wounds Using Standardized Wound Swabbing for Individualized Diagnostics and Targeted InterventionsJulian-Dario Rembe, Waseem Garabet, Jan-Wilm Lackmann, et al.
European Journal of Dermatology : EJD|May 21, 2014
Randomized standard-of-care-controlled trial of a silica gel fibre matrix in the treatment of chronic venous leg ulcersAnneke Brown, Matthias Augustin, Michael Jünger, et al.
Dermatology and Therapy|April 2, 2026
Retention, Effectiveness, and Safety of Secukinumab in Plaque Psoriasis: 5-Year Results from SERENAMatthias Augustin, Paul-Gunther Sator, Ralph von Kiedrowski, et al.
The British Journal of Dermatology|April 29, 2022
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)Thomas Bieber, Kristian Reich, Carle Paul, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 18, 2018
Lebensqualität und Behandlungsziele bei Psoriasis aus Patientensicht: Ergebnisse eines österreichweiten Querschnitt-SurveyPeter Wolf, Wolfgang Weger, Franz Legat, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 18, 2018
Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional surveyPeter Wolf, Wolfgang Weger, Franz Legat, et al.
Dermatology and Therapy|September 15, 2025
Comparative Analysis of Patient-Reported Outcomes in Chronic Pruritus: Patients with Chronic Liver or Kidney Diseases Exhibit Higher Psychological Distress than Those with Atopic DermatitisSvenja Royeck, Christian Mess, Angelika Weigel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2022
S2k guideline: Diagnosis and treatment of chronic pruritusSonja Ständer, Claudia Zeidler, Matthias Augustin, et al.
Pageof 50

Showing results (421-430 of 491) with videos related to

Sort By:
Pageof 50
American Journal of Clinical Dermatology|November 15, 2024
Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III StudiesEric L Simpson, Matthias Augustin, Diamant Thaçi, et al.
Psoriasis (Auckland, N.Z.)|May 20, 2024
Perception and Impact of COVID-19 Pandemic in Psoriasis Patients: Data from the German PsoBest and the CoronaBest RegistriesMaría José Valencia López, Brigitte Stephan, Anna Meineke, et al.
Biomedicines|October 26, 2024
Assessment and Monitoring of the Wound Micro-Environment in Chronic Wounds Using Standardized Wound Swabbing for Individualized Diagnostics and Targeted InterventionsJulian-Dario Rembe, Waseem Garabet, Jan-Wilm Lackmann, et al.
European Journal of Dermatology : EJD|May 21, 2014
Randomized standard-of-care-controlled trial of a silica gel fibre matrix in the treatment of chronic venous leg ulcersAnneke Brown, Matthias Augustin, Michael Jünger, et al.
Dermatology and Therapy|April 2, 2026
Retention, Effectiveness, and Safety of Secukinumab in Plaque Psoriasis: 5-Year Results from SERENAMatthias Augustin, Paul-Gunther Sator, Ralph von Kiedrowski, et al.
The British Journal of Dermatology|April 29, 2022
Efficacy and safety of baricitinib in combination with topical corticosteroids in patients with moderate-to-severe atopic dermatitis with inadequate response, intolerance or contraindication to ciclosporin: results from a randomized, placebo-controlled, phase III clinical trial (BREEZE-AD4)Thomas Bieber, Kristian Reich, Carle Paul, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 18, 2018
Lebensqualität und Behandlungsziele bei Psoriasis aus Patientensicht: Ergebnisse eines österreichweiten Querschnitt-SurveyPeter Wolf, Wolfgang Weger, Franz Legat, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 18, 2018
Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional surveyPeter Wolf, Wolfgang Weger, Franz Legat, et al.
Dermatology and Therapy|September 15, 2025
Comparative Analysis of Patient-Reported Outcomes in Chronic Pruritus: Patients with Chronic Liver or Kidney Diseases Exhibit Higher Psychological Distress than Those with Atopic DermatitisSvenja Royeck, Christian Mess, Angelika Weigel, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|October 17, 2022
S2k guideline: Diagnosis and treatment of chronic pruritusSonja Ständer, Claudia Zeidler, Matthias Augustin, et al.
Pageof 50